Doug Schenkel

Stock Analyst at UBS

(4.95)
# 130
Out of 5,136 analysts
429
Total ratings
65%
Success rate
25.7%
Average return

Stocks Rated by Doug Schenkel

Twist Bioscience
Nov 16, 2026
Maintained: Hold
Price Target: $60 → $120
Current: $111.60
Upside: +7.53%
HeartFlow
Nov 16, 2026
Reiterated: Hold
Price Target: $60
Current: $48.46
Upside: +23.81%
Qiagen
Nov 13, 2026
Rated: Hold
Price Target: $50
Current: $49.89
Upside: +0.22%
Pacific Biosciences of California
Nov 9, 2026
Rated: Hold
Price Target: $2.7
Current: $1.96
Upside: +37.76%
10x Genomics
Nov 9, 2026
Rated: Hold
Price Target: $68 → $61
Current: $58.19
Upside: +4.83%
Veracyte
Nov 9, 2026
Rated: Buy
Price Target: $65 → $35
Current: $24.33
Upside: +43.86%
Stevanato Group
Nov 4, 2026
Reiterated: Hold
Price Target: $23 → $16
Current: $15.80
Upside: +1.27%
Tempus AI
Nov 2, 2026
Reiterated: Hold
Price Target: $70 → $80
Current: $71.60
Upside: +11.73%
West Pharmaceutical Services
Oct 30, 2026
Reiterated: Buy
Price Target: $415 → $495
Current: $416.42
Upside: +18.87%
Repligen
Oct 28, 2026
Reiterated: Buy
Price Target: $225 → $235
Current: $167.79
Upside: +40.06%
Reiterated: Buy
Price Target: $250 → $260
Current: $233.02
Upside: +11.58%
Reiterated: Buy
Price Target: $730 → $800
Current: $700.22
Upside: +14.25%
Reiterated: Hold
Price Target: $165 → $180
Current: $173.96
Upside: +3.47%
Reiterated: Buy
Price Target: $105 → $175
Current: $115.89
Upside: +51.01%
Initiated Coverage: Hold
Price Target: 300p
Current: 238p
Upside: +26.16%
Reiterated: Buy
Price Target: $75 → $225
Current: $151.70
Upside: +48.32%
Upgraded: Buy
Price Target: $150 → $260
Current: $207.01
Upside: +25.60%
Reiterated: Buy
Price Target: $135 → $435
Current: $319.09
Upside: +36.33%
Upgraded: Buy
Price Target: $480 → $490
Current: $460.25
Upside: +6.46%
Upgraded: Buy
Price Target: $60
Current: $61.59
Upside: -2.58%
Reiterated: Hold
Price Target: n/a
Current: $15.54
Upside: n/a
Initiated Coverage: Buy
Price Target: $32
Current: $23.04
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $5.66
Upside: n/a
Initiated Coverage: Hold
Price Target: n/a
Current: $1,738.91
Upside: n/a
Initiated Coverage: Buy
Price Target: €265.00
Current: €290.50
Upside: n/a
Initiated Coverage: Hold
Price Target: n/a
Current: $7.54
Upside: n/a
Initiated Coverage: Hold
Price Target: n/a
Current: $154.39
Upside: n/a
Initiated Coverage: Buy
Price Target: n/a
Current: $8.21
Upside: n/a
Initiated Coverage: Hold
Price Target: n/a
Current: $8.45
Upside: n/a
Initiated Coverage: Buy
Price Target: n/a
Current: $2.01
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: -
Upside: n/a
Reiterated: Buy
Price Target: $18 → $25
Current: $1.16
Upside: n/a
Reiterated: Buy
Price Target: $17 → $26
Current: $4.13
Upside: n/a
Initiated Coverage: Buy
Price Target: n/a
Current: $9.74
Upside: n/a
Initiated Coverage: Buy
Price Target: n/a
Current: $1.57
Upside: n/a
Reiterated: Buy
Price Target: $540
Current: $83.33
Upside: n/a
Initiated Coverage: Buy
Price Target: n/a
Current: $13.29
Upside: n/a
Reiterated: Buy
Price Target: $85 → $90
Current: $20.07
Upside: n/a
Reiterated: Hold
Price Target: $10 → $4
Current: $0.7074
Upside: n/a
Initiated Coverage: Buy
Price Target: n/a
Current: $29.04
Upside: n/a
Initiated Coverage: Buy
Price Target: n/a
Current: $15.71
Upside: n/a
Reiterated: Buy
Price Target: $110
Current: $152.48
Upside: n/a
Reiterated: Buy
Price Target: $250 → $275
Current: $218.03
Upside: n/a
Initiated Coverage: Buy
Price Target: n/a
Current: $2.93
Upside: n/a